venous-thromboembolism

Documents about venous-thromboembolism

• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism#904609ClinicalTrials.gov
• Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)#886012ClinicalTrials.gov
• Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis#888536ClinicalTrials.gov
• Risk factors of venous thromboembolism in ICU patients: a systematic review and meta-analysis#4747Europe PMC
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19#895942ClinicalTrials.gov
• Study on the Clinical Course Of Pulmonary Embolism#158089ClinicalTrials.gov
• Inpatient Characteristics and Outcomes of Venous Thromboembolism Among Children and Adolescents.#275643NCBI PubMed Central
• European Active Surveillance Study (EURAS)#829073ClinicalTrials.gov
• AQT90 FLEX D-dimer Clinical Sensitivity and Specificity#966447ClinicalTrials.gov
• Coagulation After Intravenous Methylprednisolone Administration#980913ClinicalTrials.gov
• THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)#1009021ClinicalTrials.gov
• Glioblastoma Remote Monitoring and Care - Research Protocol#1031876ClinicalTrials.gov
• Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer#450643S-Space: Seoul National University
• Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer#980283ClinicalTrials.gov
• Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies#802013ClinicalTrials.gov
• Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)#966489ClinicalTrials.gov
• Explainable machine learning for predicting venous thromboembolism in septic shock patients.#427833NCBI PubMed Central
• Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study#834015ClinicalTrials.gov
• Aspirin and Enoxaparin for VTE in Trauma#878366ClinicalTrials.gov
• Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS#897223ClinicalTrials.gov
• Safety of Dabigatran Etexilate in Blood Clot Prevention in Children#908169ClinicalTrials.gov
• Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer#969897ClinicalTrials.gov
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis#899511ClinicalTrials.gov
• Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients#805720ClinicalTrials.gov
• Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis#872542ClinicalTrials.gov
• Extracellular RNA Induces Neutrophil Recruitment Via Toll‐Like Receptor 3 During Venous Thrombosis After Vascular Injury#971309HAL (France)
• VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy#217043ClinicalTrials.gov
• LMWH Compliance in Pregnancy#804060ClinicalTrials.gov
• STAT-STatin and Aspirin in Trauma#806414ClinicalTrials.gov
• Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study#810958ClinicalTrials.gov
• VTE Prevention Following Total Hip and Knee Arthroplasty#860988ClinicalTrials.gov
• Toronto Thromboprophylaxis Patient Safety Initiative#909808ClinicalTrials.gov
• Table 2_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347347Figshare
• Table 1_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347348Figshare
• Table 4_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347349Figshare
• Table 3_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347350Figshare
• A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).#836651ClinicalTrials.gov
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery#850361ClinicalTrials.gov
• Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose#802249ClinicalTrials.gov
• Evaluation of the Duration of Therapy for Thrombosis in Children#836389ClinicalTrials.gov
• Oral Anticoagulants and Risk of Bleeding and Death in Cancer-Associated Venous Thromboembolism.#244405NCBI PubMed Central
• Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.#268891IRIS
• Artificial intelligence for venous thromboembolism risk stratification in surgical patients: a systematic review.#342515NCBI PubMed Central
• A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery#859629ClinicalTrials.gov
• Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis#907799ClinicalTrials.gov
• Comment on Murphy et al.: pediatric orthopaedic lower extremity trauma and venous thromboembolism#934576Koc University Digital Collections
• Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism#847210ClinicalTrials.gov
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery#901123ClinicalTrials.gov
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy#1029956ClinicalTrials.gov
• Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)#836225ClinicalTrials.gov